Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: margie who wrote (4990)	7/24/1998 4:29:00 PM
From: Henry Niman	Respond to of 6136

margie, I'm not sure why you think a favorable article in the WSJ on Viracept or an article in today's NY Times syndicate "Your Health Daily": yourhealthdaily.com would be considered cluttering up this thread (since Viracept is a PI and it's AGPH main revenue source). As far as the poster that I had mentioned on the LGND thread is concerned, he's been posting several to dozens of posts per day for almost a year (and although he probably has no LGND position, he posts there almost exclusively). I do visit this thread occasionally, but fail to see how the posts that I put up today could fall into the "cluttering up" category. As you know, LGND has moved into the metabolic disease area, and their rexinoids and TZDs may well have applications for AIDS patients with altered metabolisms.